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ABSTRACT
Labor pain is not only an unpleasant mental experience, but one of the most important factors that may negatively affect 
the course of labor and the well-being of the fetus. Over the years, many techniques for relieving labor pain have been 
developed, ranging from non-pharmacological (acupuncture, TENS, hypnosis...), through opioids and aeriform anesthetics, 
to regional analgesia techniques. Numerous studies and meta-analyzes prove that central blockades are the gold standard 
of labor analgesia and debunk the myths that these blockages are negatively limited to the course of labor. In the light of 
recent studies, the claim that epidural analgesia increases the risk of termination by caesarean section should be rejected. 
It has also been proven that central blockades do not lower the child’s APGAR score. Feeling, an indication to use a central 
block during labor, should be a subjective intolerance to pain and the wishes of the mother in labor. The review presents the 
directions of development and the current state of knowledge of modern medicine regarding various anesthesia techniques, 
their safety for the mother, fetus and newborn, as well as practical tips to increase the satisfaction of the mother in labor.
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INTRODUCTION
Anaesthesia of a pregnant woman, regardless of the 
duration of pregnancy, is always a great challenge for the 
anaesthesiologist and requires close multidisciplinary co-
operation. It is associated with a measurable risk to the 
mother and the fetus arising from the applied procedure. 
Qualified personnel and specialized equipment, as well 
as the ability to perform various types of anesthesia and 
fluent knowledge of the effects of the drugs used allow 
to predict and effectively prevent possible complica-
tions. The review presents the directions of development and 
the current state of knowledge of modern medicine re-
garding various anaesthesia techniques, their safety for 
the mother, fetus and newborn, as well as practical tips to 
increase the satisfaction of the mother in labor.
QUALIFICATION FOR THE ANESTHESIA
The location of the pathology requiring surgical treat-
ment of the pregnant woman determines the choice of 
the possible anesthesia technique. The anaesthesiologic 
consultation should be performed earlier and allows a de-
tailed explanation of the procedures, optimization of the 
general condition, commissioning the necessary specialist 
consultations and additional laboratory or imaging tests. 
The proposed techniques of anaesthesia should be selected 
taking into account the indications and contraindications and 
should be as safe as possible for the mother and the fetus.
ANAESTHETIC DRUGS
The effects of drugs on rapidly dividing cells in the first 
trimester of pregnancy may be teratogenic and lead to se-
vere disorders of organogenesis, including severe congenital 
abnormalities of the fetus, including pregnancy loss. We do 
not have randomized trials assessing the teratogenic effects 
of anaesthetic drugs on the fetus, but it seems that the doses 
of routinely used anaesthetic drugs for various anaesthetic 
techniques are safe. This is confirmed by the analysis of the 
material collected in the National Study of the Prevention of 
Birth Defects in the United States, which showed that general 
or regional anaesthesia to pregnant women for dermato-
logical, dental or gynaecological procedures, mainly in the 
cervical area, regardless of the duration of pregnancy, was 
not associated with the occurrence of 25 analyzed congenital 
malformations assessed in the study [1]. 
The hypnotic drugs used for the induction of general 




amine. Propofol and thiopental cause comparable haemo-
dynamic changes in the mother, and the Apgar assessment 
of the newborn does not differ significantly depending on 
which of them was used [2]. Unlike ketamine, after which 
a significantly higher number of newborns are born with 
a lower Apgar result at one and five minutes when used for 
general anesthesia, compared to thiopental [3].
Used intravenously as a co-analgesic for caesarean sec-
tion under spinal anaesthesia, it enhances the effect of local 
anaesthesia drugs, significantly extends the time of effective 
postoperative analgesia without significant adverse effects 
for the mother, typical for opioids [4].
Opioid drugs used in obstetrics for general anaesthesia 
or central blockers are fentanyl, remifentanil, sufentanil and 
morphine. They easily overcome the placental barrier, may 
cause respiratory depression in the fetus and affect the Ap-
gar score in the newborn, but it seems that this difference 
compared to non-opioid analgesia is not clinically signifi-
cant [5]. Remifentanil is a short-acting opioid for induction 
and maintenance of anaesthesia and is administered as 
a continuous infusion. It can cause short-term respiratory 
depression in the newborn requiring tactile stimulation, 
and even short-term mask ventilation, while it provides 
the mother with excellent hemodynamic stability and may 
reduce recovery during cesarean section [6]. 
Dexmedetomidine at a dose of 5 µg administered suba-
rachnoid together with bupivacaine for caesarean section 
enhances the anesthetic effect of bupivacaine, prolongs the 
duration of sensory blockade and analgesia, and reduces 
the need for other analgesics [7]. Lipophilic opioids are 
used as adjuvants in central blockades. Fentanyl at a dose 
of 25 µg and sufentanil at a dose of 5 µg in combination 
with hyperbaric bupivacaine used for spinal anesthesia of 
caesarean section are characterized by comparable effec-
tiveness, they are safe for the mother and the fetus, while 
the analgesic effect of sufentanil lasts longer [8]. Sufentanil 
has no negative effects on the fetus due to its binding to 
alpha1-glycoprotein at doses below 30 µg.
ANAESTHESIA FOR THE NATURAL DELIVERY
Commonly used techniques of natural birth anaesthesia 
include central blockades — epidural analgesia (EA), com-
bined spinal — epidural analgesia CSE, its variant (dural 
puncture epidural analgesia DPE) and continuous subarach-
noid anaesthesia (CSA). An alternative to them is intravenous 
analgesia with remifentanil. The techniques listed above are 
combined with patient-controlled analgesia PCA [9]. 
CENTRAL BLOCKADES
All central blocks used to conduct continuous analgesia 
of natural labor involve the necessity of placing the catheter 
in the appropriate space of the spine. EA, CSE and DPE begin 
with the location of the epidural space most often using 
a Tuohy needle with the resistance drop method. Depending 
on the technique chosen, a thinner 25–27 G subarachnoid 
needle is inserted through the epidural needle and the 
dura mater is punctured, reaching the subarachnoid space, 
where a local anesthetic drug (CSE) is administered [9], or 
after puncturing the dura, the needle is extended without 
administration of the drug, leaving a hole (DPE) in it [10]. 
Finally, in all the above-mentioned techniques, a catheter 
is inserted into the epidural space through a Tuohy needle 
for continuous analgesia. Early catheter placement is par-
ticularly important in the case of possible complications 
throughout the course of labor on the part of pregnant 
woman (severe obesity, twin pregnancy, pre-eclampsia), 
or the anaesthesiologist expects difficulties in securing the 
respiratory tract of the woman [11]. 
In the DPE technique, the opening left in the dura al-
lows the local anaesthetic drug to translocate freely into 
the subarachnoid space; Compared to epidural anaesthesia, 
it has a stronger effect on the roots of the sacral nerves 
and unilateral block develops less frequently. The fastest 
analgesic effect, on average after two to five minutes, is 
achieved with CSE, while the same level of anesthesia 
is achieved only after 15–20 minutes with EA. All the tech-
niques may extend the duration of labor, increase the risk 
of instrumental extraction of the fetus, epidural hematoma 
or urinary retention [12]. 
Local anesthetic drugs that are particularly useful in 
obstetrics include bupivacaine, levobupivacaine, and ropi-
vacaine. Ropivacaine in minimally levels overcomes the 
placental barrier, gives a sensory blockade comparable to 
bupivacaine, and less motor blockade, and it is less toxic 
to the cardiovascular and central nervous systems [13]. 
Sufentanil added to a local anesthetic in CSA accelerates 
the onset of sensory blockade, extends its duration and 
enhances the analgesic effect of local anaesthetics, a lower 
negative hemodynamic effect is observed, and achieves 
effective analgesia with maintained mobility and negligible 
toxicity to the fetus, however, to reduce uterine contractile 
activity and extend the duration of labor [14].
Epidural anaesthesia of natural labor is performed con-
tinuously — (continuous epidural infusion CEI) or intermit-
tently, performed by an anaesthesiologist administering 
single boluses of a specific volume of the drug mixture, at 
specified intervals or automatically — using a programmed 
intermittent epidural pump (programmed intermittent 
epidural bolus PIEB). Studies show that continuous epi-
dural with low basal flow combined with patient-controlled 
analgesia for PCEA for breakthrough pain relief increases 
medication use and more frequently requires an additional 
analgesic bolus, while high basal infusion reduces the inci-
dence of breakthrough pain but increases motor block and, 
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consequently, the need for instrumental extraction of the 
fetus and the risk of shoulder dystocia [15].
According to Wong, the onset of natural labor using 
CEI may differ depending on the anaesthesia technique 
used — EA or CSE, as well as the moment at which analgesia 
begins (first or second stage of labor). EA regardless of the 
stage of labor is started with a bolus of 5–15 mL of a mixture 
of 0.0625–0.125% bupivacaine with fentanyl 1–2 µg/mL 
(50–100 µg) or with sufentanil 0.2–0.3 µg/mL (5–10 µg), 
and CSE, if it begins in the first stage of labor, an opioid is 
effective in minimizing pain — e.g., 25 µg subarachnoid 
fentanyl, while a mixture of bupivacaine 1.25 is more ef-
fective if it begins in the late first or second stage of labor 
— 2.5 mg with 15 µg fentanyl administered subarachnoid. 
The maintenance of CEI in the above scheme is achieved 
using a constant infusion of bupivacaine 0.05–0.1% with 
fentanyl 1–2 µg/mL or sufentanil 0.2–0.3 µg/mL at a rate 
of 8–15 mL/h [16]. If PCEA is added to the CEI, the scheme 
may be as follows: basic infusion of a mixture of 0.05–0.1% 
bupivacaine with 1.5–3 µg/mL fentanyl or 0.20–0.33 µg/mL 
sufentanil at a rate of 5–8 mL/h; PCEA bolus 5–10 mL, with-
drawal period 10–20 minutes [17].
PIEB of the first stage of natural labor with bupivacaine: 
after the test dose (3 mL 0.125% bupivacaine with 3.3 µg/mL 
fentanyl) with an interval of three minutes. administration 
of 6 mL of a mixture of 0.125% bupivacaine with 3.3 µg/mL 
fentanyl twice to obtain a full loading dose. Anaesthesia 
maintenance: mixture of 0.0625% bupivacaine with 2 µg/mL 
fentanyl, bolus 10–12 mL/h, the first one hour after the 
loading dose and each subsequent one after 40 minutes, 
PCEA bolus of the same 5 mL mixture, withdrawal period 
10 minutes. up to a maximum dose of 30 mL/h [18].
The most effective analgesic effect is achieved if the in-
tervals between consecutive boluses do not exceed 40 min-
utes. Using higher concentrations of bupivacaine during 
first-stage analgesia bupivacaine 0.125% with 2 µg/mL fen-
tanyl, a bolus volume of 5 mL provides effective analgesia if 
the bolus interval is 35 minutes; however, more often there 
is a sensory blockage exceeding the Th6 level [19].
PIEB of the first stage of natural labor with ropivacaine: 
after the test dose (3 mL 1.73% Lidocaine carbonate), admin-
istration of the full loading dose of a mixture of 0.08% ropiv-
acaine with 0.3 µg/mL of sufenanil in the amount of 10 mL, 
maintenance of anaesthesia: 10 mL bolus of the mixture, 
the first hour after the loading dose and each subsequent 
PCEA bolus of the same mixture every 42 minutes — the first 
10 mL, the next 5 mL, withdrawal period 10 minutes. Such 
a scheme allows to avoid motor blockade and hypotension; 
however, it requires further studies to assess its effectiveness 
throughout the delivery [20].
Comparison of the effectiveness of analgesic therapy 
and the severity of side effects of anaesthesia of natural 
labor using CEI + PCEA vs PIEB + PCEA show that PIEB has 
an advantage over the continuous technique, provides 
comparable analgesia with lower drug consumption, gives 
greater satisfaction to the mother and a lower risk of side 
effects in the form of hypotension or motor block resulting 
in the necessity of instrumental extraction of the fetus [21].
Advantage of PIEB + PCEA (0.1% ropivacaine + 2 µg/mL 
fentanyl, 5–10 mL bolus every 1 hour, PCEA 5 mL bolus, 
withdrawal period 10 min.), Compared to CEI (0.2% ropiv-
acaine + 2 µg/mL/mL fentanyl, infusion 5–15 mL/h) has also 
been shown during second-stage anesthesia, indicating that 
the intermittent method is associated with a lower risk of 
motor blockade, a shorter second stage of labor in primipa-
rous women, without affecting its duration in multiparous 
women and a reduction in the total dose ropivacaine [22].
Continuous spinal anaesthesia
Continuous spinal anaesthesia (CSA) is relatively rarely 
used in obstetrics due to the high rate of post-dural head-
aches and difficulties in placing the catheter in the desired 
location in the subarachnoid space. Compared to CEI or 
single subarachnoid single-shot spinal anesthesia (SSA), 
it is characterized by the possibility of obtaining a precisely 
defined amount of sensory blockade tailored to the needs, 
using small, titrated doses of drugs, which allows better con-
trol of hemodynamic changes following sympathetic block-
ade [23]. With the use of CSA, it is possible to perform both 
natural delivery and caesarean section [24]. Labor analysis is 
performed using a mixture of 0.1% ropivacaine with 2 µg/mL 
fentanyl or 0.0625% bupivacaine with 2 µg/mL fentanyl by 
continuous infusion at a rate of 2 mL/h; Breakthrough pains 
require a bolus of 2 mL of the used mixture at an interval of 
at least 15 minutes, provided that the maximum number of 
additional doses does not exceed 3 per hour [25]. Remember 
to increase the starting dose by the dead space volume of 
the catheter used. A catheter inserted into the subarachnoid 
space can be used for caesarean section. The starting dose 
is 5–7.5 mg of 0.5% isobaric bupivacaine or 0.75% of hyper-
baric bupivacaine; subsequent doses of 2.5 mg of the agent 
used should be added every three to five minutes in order 
to obtain the desired level of anaesthesia [25]. 
Intravenous analgesis
Intravenous analgesia is an alternative method of reliev-
ing labor pain to central blockades. It is carried out with the 
use of intramuscular or intravenous opiates, most often in 
the form of patient-controlled analgesia (PCA). Remifen-
tanil (PCA-R) — a short-acting opioid with a metabolism 
independent of the liver and kidneys — has turned out 
to be particularly useful recently. Provides quick analgesia 
with high satisfaction of the giving birth compared to other 




analysis; in addition, PCA-R increases the risk of maternal ap-
nea, desaturation, nausea, vomiting and sedation, without 
reducing the Apgar score below seven in the fifth minute 
in neonates compared to EA, and the risk of cesarean de-
livery is comparable to EA/CSE [26]. In the RESPITE study, 
the object was to compare the effectiveness of the analge-
sic effect of PCA-R (40 ug bolus on demand, 2 min. block-
ade) with intramuscular pethidine (100 mg every 4 hours, 
up to 400 mg/d) during labor, showed that PCA-R reduces 
by half the necessity to perform additional AE in order to 
satisfactorily eliminate the pain enabling the termination of 
natural labor. Good clinical practice of labor anesthesia with 
the use of opioid PCA requires constant monitoring of the 
saturation of arterial blood in the pregnant woman, assess-
ment of the degree of sedation and pain using dedicated 
scales, blood pressure measurement, one-to-one care and 
CTG monitoring [27].
New randomized trials comparing PCA-R with PIEB con-
firm that PCA-R is a safe alternative for the mother, fetus and 
newborn, and has low side effects in the form of sedation, 
nausea and vomiting. Even in some respects, some research-
ers have recognized an advantage of PCA-R over epidural 
techniques, especially in terms of shortening the duration of 
the first stage of labor or a higher spontaneous delivery rate 
without adversely affecting the mother or the newborn [28].
Inhalation analgesia of labor
Inhalation analgesia of labor is often described as ar-
chaic, it is based on the use of a mixture of nitrous oxide 
with oxygen in the ratio 1:1 — Entonox. Nitrous oxide thanks 
to its short half-life - less than three minutes and low blood 
solubility. It is absolutely safe for the child and mother during 
delivery [29]. Intermittent use of LIVOPAN to relieve labor 
pain until the end of the second stage of labor, compared 
to inhalation of pure oxygen, brings significant relief to 
the mother, reduces the need for intravenous pethidine 
0.5 mg/kg and increases maternal satisfaction and is safe 
for the fetus [30]. The main advantages of N2O as an anal-
gesic during labor are its favorable pharmacological profile 
(quick onset and rapid rinse out 30–50 s) and the possibility 
of inhalation by the patient herself, who controls its admin-
istration [31].
ANAESTHESIA FOR CESAREAN SECTION
The lack of vaginal labor progress, fatigue of the 
woman in labor despite pharmacotherapy, ineffective 
obstetric maneuvers to induce uterine contractions, and 
deteriorating fetal well-being, mainly due to impending 
asphyxia, are associated with the need to terminate deliv-
ery by caesarean section. The obstetrician decides about 
the conversion to cesarean section. Depending on the cir-
cumstances, the presence or absence of urgent obstetric 
indications for termination of pregnancy, as well as the skills 
and experience of the anesthesiologist and equipment, we 
can choose from EA, CSE, DPE, CSA, SSA or general anesthe-
sia. Central locks are preferred. When deciding to perform 
EA for Caesarean section, which has a negligible impact on 
the mother and the fetus, one should consider a delayed 
onset of action compared to CSE (18.3 vs 9.7 minutes), as 
well as the risk of incomplete sensorimotor blockade and 
insufficient muscle relaxation [32]. Sufentanl in a dose of 
15–20 µg as an adjuvant added to 0.65% ropivacaine in EA 
is effective in relieving intraoperative somatic-visceral pain 
during strong traction of abdominal organs during caesar-
ean section performed in multiparous women with uterine 
scar following previous cesarean sections; the use of higher 
doses of sufentanil increases the risk of side effects associ-
ated with the opioid (nausea, vomiting, hypotension). In the 
aforementioned group of women, an effective supplemen-
tation of EA is PCA-R in a dose of 0.025–0.05 µg/kg/min, the 
use of which guarantees sedation and significantly improves 
the satisfaction of the mother in labor [33].
The great popularity of CSE is due to the possibility of 
continuing analgesic treatment after cesarean section by 
the epidural price list. For spinal anesthesia, hyperbaric 
0.5–0.75% bupivacaine in a dose of 7.5–12.5 mg is used in 
combination with an opioid (fentanyl, sufentanil, morphine) 
— fentanyl 10–20 μg, sufentanil 5 μg, morphine 0.2–0.3 mg. 
Previous suggestions that low doses of bupivacaine (< 8 mg) 
used during spinal anesthesia causes lower pressure drops 
and other side effects have not been confirmed because 
the quality of this anaesthesia is insufficient and requires 
additional painkillers [34]. 
Hypotension following anaesthesia is a serious problem 
concerning central blockades, especially SSA. Severe or 
persistent hypotension contributes to maternal dizziness, 
nausea and vomiting. Ephedrin, phenylephrine and norepi-
nephrine are sympathomimetics of alpha receptors, their 
action guarantees an increase in blood pressure. They act 
on beta receptors to a different extent, ephedrin the strong-
est — it causes tachycardia in the mother and increases the 
demand for oxygen [35]. It easily crosses the placental bar-
rier, increases fetal metabolism and may contribute to fetal 
acidosis. Phenylephrin is almost beta-negative and therefore 
causes reflex bradycardia that lasts 20 minutes after IV and 
50 minutes after administration of SC Norepinephrine is also 
an almost selective agonist of alpha receptors, it poorly pen-
etrates the placenta, it works for about 60 seconds, thanks to 
which it is easily controllable during administration. Used to 
treat hypotension during SSA for cesarean delivery (infusion 
of 4ug/min NA, beginning at 2.5–2.7 mL 0.6% subarach-
noid hyperbaric ropivacaine) reduces the risk of maternal 
tachycardia and provides greater hemodynamic stability 
compared to with ephedrine infusion 4 mg/min. [36]. Nor-
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epinephrine provides better hemodynamic stability and is 
less likely to cause bradycardia compared to phenylephrine.
GENERAL ANESTHESIA
General anesthesia of a pregnant woman for each pro-
cedure, including caesarean section, is the least frequently 
chosen option. The most common reasons are immediate 
or urgent indications for surgery, lack of time to perform 
a central block or insufficient scope of anaesthesia obtained 
thanks to regional anaesthesia [11]. Coagulation disorders, 
intracranial hypertension, systemic infection or infection 
in the puncture area in a pregnant woman make it impos-
sible to perform a central block, while vaginal bleeding 
or eclampsia force the obstetrician to decide on immedi-
ate termination of pregnancy. Close cooperation between 
an anaesthesiologist and an obstetrician gynecologist is re-
quired. Apart from the constant assessment of the pregnant 
woman’s vital functions in the perioperative period, the fetal 
heart rate and uterine contractions should be monitored.
From 12 Hbd, a pregnant woman should always be 
treated as a person with a “full stomach” regardless of the 
time of eating the last meal - obligatory for 30 minutes. prior 
to anesthesia, antacids should be administered, and admin-
istration of a histamine H2 receptor antagonist should be 
considered [11]. The pregnant patient should be properly 
positioned — with rotation to the left side, in the anti-trend 
position (prophylaxis of the inferior vena cava syndrome and 
strengthening of the lower esophageal sphincter). Induction 
of general anesthesia must be rapid and fluent [rapid-se-
quence intubation (RSI)] due to the risk of aspiration of food 
content, reliable 3–5 minutes pre-oxygenation (avoiding 
apnea due to very low respiratory reserve — hypoxia and 
hypercapnia during induction of anesthesia causes acidosis 
in fetus), with oxygen flow above 10l/min. through a fully 
sealed mask with capnographic monitoring [37]. Common 
practice in obstetric patients should be the use of propofol 
and rocuronium (1.2 mg/kg) with access to sugammadex, 
succinylcholine (1.5–2 mg/kg) is also acceptable, unless there 
are contraindications; Tracheal intubation remains the gold 
standard, and both propofol and sevoflurane are suitable 
for the maintenance of anesthesia. N2O is also a good op-
tion or addition to an inhalation anesthetic. All halogenated 
inhalation anesthetics in equivalent concentrations produce 
a comparable dose-dependent reduction in uterine contrac-
tion and a reduction in resting tone. This effect disappears 
quickly after their supply in the breathing mixture is discon-
tinued. Used in high flow rates, they can lead to uterine atony 
and life-threatening hemorrhage immediately after delivery. 
CONCLUSIONS
The paper presents the latest achievements in mod-
ern medicine concerning the pathways of anesthetic man-
agement with a pregnant woman requiring anesthesia. 
The safety and health of the mother, fetus and newborn 
baby are of paramount importance to the medical and 
nursing team that takes care of them, carries out diagnostic 
procedures or performs complex operating procedures.
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